Invited Speakers:
|
|
Elodie Belnoue, CMU, Switzerland Robert Coffman, Dynavax Technologies, Berkeley, California Andrea Cooper, Trudeau Institute, Inc., New York Heather Davis, Coley Pharmaceutical Group, Kanata, Canada Lucy Dorrell, John Radcliffe Hospital, UK Simon Draper, Wellcome Trust Centre for Human Genetics, UK Beatrix Grubeck-Loebenstein, Austrian Academy of Sciences, Innsbruck, Austria Kim Hasenkrug, Rocky Mountain Laboratories, NIAID,NIH, Montana Dan Littman, HHMI/Skirball Institute of Biomolecular Medicine,New York, New York Janet McElaney, University of Connecticut, Farmington, CT Benedita Rocha, INSERM U591, Paris, France Stephen Schoenberger, La Jolla Institute for Allergy & Immunology, CA Robert Seder, Vaccine Reserach Center, NIAID, NIH, Bethesda, Maryland Alan Shaw, Vaxinnate Corporation, New Jersey Alan Sher, National Institute of Allergy & Infectious Diseases, Bethesda, Maryland
|
|